These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

553 related items for PubMed ID: 24961747

  • 21. Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome.
    Nuri E, Taraborelli M, Andreoli L, Tonello M, Gerosa M, Calligaro A, Argolini LM, Kumar R, Pengo V, Meroni PL, Ruffatti A, Tincani A.
    Immunol Res; 2017 Feb; 65(1):17-24. PubMed ID: 27406736
    [Abstract] [Full Text] [Related]

  • 22. The clinical significance of autoantibodies directed against prothrombin in primary antiphospholipid syndrome.
    Hoxha A, Ruffatti A, Pittoni M, Bontadi A, Tonello M, Salvan E, Plebani M, Punzi L.
    Clin Chim Acta; 2012 May 18; 413(9-10):911-3. PubMed ID: 22349599
    [Abstract] [Full Text] [Related]

  • 23. A contribution to detection of anticardiolipin and anti-β2glycoprotein I antibodies: Comparison between a home-made ELISA and a fluorescence enzyme immunoassay.
    Mattia E, Ruffatti A, Meneghel L, Tonello M, Faggian D, Hoxha A, Fedrigo M, Punzi L, Plebani M.
    Clin Chim Acta; 2015 Jun 15; 446():93-6. PubMed ID: 25892672
    [Abstract] [Full Text] [Related]

  • 24. Autoantibody response to adjuvant and nonadjuvant H1N1 vaccination in systemic lupus erythematosus.
    Urowitz MB, Anton A, Ibanez D, Gladman DD.
    Arthritis Care Res (Hoboken); 2011 Nov 15; 63(11):1517-20. PubMed ID: 22034113
    [Abstract] [Full Text] [Related]

  • 25. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec 15; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 26. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O, Crippa L, Della Valle P, Sabbadini MG, Viganò D'Angelo S, D'Angelo A.
    Haematologica; 1999 Sep 15; 84(9):829-38. PubMed ID: 10477458
    [Abstract] [Full Text] [Related]

  • 27. Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.
    Stojanovich L, Kontic M, Djokovic A, Marisavljevic D, Ilijevski N, Stanisavljevic N, Mikovic Z, Petkovic M, Kovcin V.
    Clin Exp Rheumatol; 2013 Sep 15; 31(2):234-42. PubMed ID: 23306109
    [Abstract] [Full Text] [Related]

  • 28. High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity.
    de Larrañaga GF, Forastiero RR, Martinuzzo ME, Carreras LO, Tsariktsian G, Sturno MM, Alonso BS.
    Lupus; 2000 Sep 15; 9(8):594-600. PubMed ID: 11035434
    [Abstract] [Full Text] [Related]

  • 29. A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010.
    Lind A, Ramelius A, Olsson T, Arnheim-Dahlström L, Lamb F, Khademi M, Ambati A, Maeurer M, Nilsson AL, Bomfim IL, Fink K, Lernmark Å.
    J Autoimmun; 2014 May 15; 50():99-106. PubMed ID: 24485154
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus.
    Campos LM, Silva CA, Aikawa NE, Jesus AA, Moraes JC, Miraglia J, Ishida MA, Bueno C, Pereira RM, Bonfa E.
    Arthritis Care Res (Hoboken); 2013 Jul 15; 65(7):1121-7. PubMed ID: 23818263
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E.
    Autoimmunity; 2009 Sep 15; 42(6):497-506. PubMed ID: 19626489
    [Abstract] [Full Text] [Related]

  • 36. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC.
    J Rheumatol; 1998 Apr 15; 25(4):667-74. PubMed ID: 9558167
    [Abstract] [Full Text] [Related]

  • 37. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
    Arvieux J, Renaudineau Y, Mane I, Perraut R, Krilis SA, Youinou P.
    Thromb Haemost; 2002 Apr 15; 87(4):599-605. PubMed ID: 12008941
    [Abstract] [Full Text] [Related]

  • 38. IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers.
    Tonello M, Mattia E, Favaro M, Del Ross T, Calligaro A, Salvan E, Hoxha A, Fedrigo M, Ruffatti A.
    Thromb Res; 2019 May 15; 177():157-160. PubMed ID: 30903876
    [Abstract] [Full Text] [Related]

  • 39. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
    Sahin M, Duzgun N, Tunc SE, Tutkak H.
    Clin Biochem; 2007 May 15; 40(8):526-30. PubMed ID: 17359958
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.